title: How can we identify new biomarkers for patients with for lung metastasectomy in colorectal cancer.
authors.affiliation: Department of Thoracic Surgery, Strasbourg University Hospital, Strasbourg, France.|EA 3430: Tumoral Progression & Micro-environment, Epidemiological & Translational Approaches, Translational Medicine Federation, University of Strasbourg, Strasbourg, France.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Renaud
authors.affiliation: Department of Thoracic Surgery, Strasbourg University Hospital, Strasbourg, France.
authors.forename: Pierre-Emmanuel
authors.initials: PE
authors.lastname: Falcoz
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology / Q000556:secondary / Q000601:surgery; D059146:Metastasectomy; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; C117307:KRAS protein, human; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D016283:Proto-Oncogene Proteins p21(ras)
keywords: BRAF; HIF; KRAS; colorectal cancer; epithelial-to-mesenchymal transition; lung metastasectomy; miRNA